Physician profile
Robert S Gilbert
NPI 1841230547
$785.03
in general payments reported to CMS, 2019-2025
17 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.10 · 2020: $117 · 2021: $135 · 2022: $29.71 · 2023: $132 · 2024: $169 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $182.24 | 2021-2025 | |
| Amgen INC. | $107.98 | 2019-2025 | Krystexxa, Repatha, Otezla |
| Lilly USA, LLC | $99.29 | 2019-2021 | |
| Glaxosmithkline, LLC. | $97.63 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $60.40 | 2020-2025 | |
| Eisai INC. | $40.50 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $24.25 | 2020 | |
| Ibsa Pharma INC. | $23.86 | 2024 | Tirosint, Licart |
| Biogen, INC. | $23.43 | 2020 | |
| Allergan, INC. | $17.86 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.20 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $17.14 | 2023 | Rexulti |
| Horizon Therapeutics Plc | $15.82 | 2022 | |
| Tolmar, INC. | $15.35 | 2025 | Jatenzo |
| Antares Pharma, INC. | $14.63 | 2023 | Tlando, Nocdurna, Xyosted |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $14.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.45 | 2024 | Spravato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.